{"url_path":"/sec/cik-0001690384/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 EXHIBITS**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1690384/0001731122-26-000715-index.html","accession_number":"0001731122-26-000715","cik":"0001690384","ticker":null,"issuer_name":"BioCrude Technologies USA, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1690384/0001731122-26-000715-index.html","primary_entity_key":"0001690384","primary_entity_name":"BioCrude Technologies USA, Inc."},"word_count":153,"has_tables":true,"body_markdown":"**ITEM 6. EXHIBITS** \n\n \n\n****\n\n \n(a)\nThe following documents are included or incorporated by reference as exhibits to this report:\n\n** **\n\n**Exhibit No.**\n \n**Description**\n\n31.1\n \n[Certification of Chief Executive Officer pursuant to Securities Exchange Act Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](e7603_ex31-1.htm)\n\n31.2\n \n[Certification of Chief Financial Officer pursuant to Securities Exchange Act Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](e7603_ex31-2.htm)\n\n32.1\n \n[Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](e7603_ex32-1.htm)\n\n \n\n \n(b)\nREPORTS ON FORM 8-K\n\n \n\nNone.\n\n \n\n45\n\n \n\n \n\n**SIGNATURES**\n\n \n\nIn accordance with Section 13 or 15 (d) of the Exchange\nAct, the registrant caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\n \n\n \nDate: May 14, 2026\n\n \n \n \n\n \n**Biocrude Technologies USA, Inc.**\n\n \nRegistrant\n\n \n \n \n\n \nBy:\n/s/ John Moukas\n\n \n \nChief Executive Officer\n\n \n\n46"}